Journal of Medicinal Chemistry · 2004 · 38 citations · 11 references
PharmacyChemistryMedicinal ChemistryDrug DiscoveryPharmacophore ModelingStructural BiologyAntiviral PharmacologyCoordination ChemistryLigand BindingMetal-ligand BondingReceptor-ligand InteractionsStructure-based Pharmacophore ModelingAntiviral Structure-activity RelationshipsCoordination Geometry DeterminationDrug-ligand ComplexationIntegrase ProteinsIntegrase Strand Transfer InhibitorsIntermolecular Metal-ligand InteractionsProtein-ligand Complex ModelingSpectroscopic Characterization
The interactions with divalent cations of 4-phenyl-4-oxo-2-hydroxybuten-2-oic acid (benzoylpyruvic acid (BPA)), the pharmacophore of HIV-1 integrase inhibitors, were investigated using spectroscopic tools. In the absence of the enzyme, a 2:2 metal-ligand complex was characterized with an intermetallic distance of 4-6 A. Molecular modeling allowed us to propose a compatible structure for the metal-ligand complex. BPA does not inhibit the reactions catalyzed by HIV-1 IN, emphasizing the importance of the aromatic ring substitution in the antiviral activity.
11
Crystal Structure of the Ribonuclease H Domain of HIV-1 Reverse Transcriptase
Jay F. Davies, Zuzana Hostomska, Zdeněk Hostomský et al. · Science · 1991 · 568 citations
Jay A. Grobler, Kara A. Stillmock, Binghua Hu et al. · Proceedings of the National Academy of Sciences · 2002 · 396 citations
Fatima Zouhiri, Jean‐François Mouscadet, Khalid Mekouar et al. · Journal of Medicinal Chemistry · 2000 · 148 citations · Full text